RxDoctor Payments Data

Dee Hubbard, MD

Obstetrics & Gynecology · Catonsville, MDNPI 1295828754

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.6% of the total across 27 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by Astellas Pharma US Inc at 30.7% of the total. Reporting peaked in 2019 at $290 and has fallen 68.6% since, to $91 in 2025. That places this record below the midpoint for obstetrics & gynecology clinicians in MD, where the typical reported total is $508.

$547in general payments, 2019–2025

Across 27 payments — averaging $20.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$168
  • AbbVie$159
  • Therapeuticsmd, Inc.$39
  • Sage Therapeutics, LLC$32
  • Bayer$29
  • Coopersurgical, Inc.$25
  • plus $96 from 6 others

What the payments were for

  • Food & beverage$53498%
  • Education$132%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$547 in reported general payments places this provider in the 50th percentile of 842 obstetrics & gynecology providers in Maryland.

See all obstetrics & gynecology providers in Maryland →

Medicare billing

Part B allowed, 2024
$7,124
Medicare patients
49
Services billed
77

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol41$2,630
ProgesteroneProgesterone, Micronized21$985
Estradiol (Once Weekly)Estradiol17$865

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in Catonsville

See the full list for Maryland →

Where these figures come from

Is this you, or does something look wrong? →